These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30976568)

  • 21. High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
    Ferro M; Vartolomei MD; Cantiello F; Lucarelli G; Di Stasi SM; Hurle R; Guazzoni G; Busetto GM; De Berardinis E; Damiano R; Perdonà S; Borghesi M; Schiavina R; Almeida GL; Bove P; Lima E; Grimaldi G; Autorino R; Crisan N; Abu Farhan AR; Verze P; Battaglia M; Serretta V; Russo GI; Morgia G; Musi G; de Cobelli O; Mirone V; Shariat SF
    Urol Int; 2018; 101(1):7-15. PubMed ID: 29975950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
    Richards KA; Smith ND; Steinberg GD
    J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated white light transurethral resection of the bladder in nonmuscle-invasive urothelial bladder cancers: systematic review and meta-analysis.
    Vianello A; Costantini E; Del Zingaro M; Bini V; Herr HW; Porena M
    J Endourol; 2011 Nov; 25(11):1703-12. PubMed ID: 21936670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M; Stotz N; Rassweiler J
    J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Naselli A; Hurle R; Paparella S; Buffi NM; Lughezzani G; Lista G; Casale P; Saita A; Lazzeri M; Guazzoni G
    Eur Urol Focus; 2018 Jul; 4(4):558-567. PubMed ID: 28753839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes and Complications of Bipolar vs. Monopolar Energy for Transurethral Resection of Bladder Tumors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Mao X; Zhou Z; Cui Y; Zhang Y; Yang M
    Front Surg; 2021; 8():583806. PubMed ID: 34150834
    [No Abstract]   [Full Text] [Related]  

  • 27. [Should we propose a systematic second transurethral resection of the bladder for all high-risk non-muscle invasive bladder cancers?].
    Lipsker A; Hammoudi Y; Parier B; Drai J; Bahi R; Bessede T; Patard JJ; Pignot G
    Prog Urol; 2014 Sep; 24(10):640-5. PubMed ID: 25214293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations.
    Klaassen Z; Kamat AM; Kassouf W; Gontero P; Villavicencio H; Bellmunt J; van Rhijn BWG; Hartmann A; Catto JWF; Kulkarni GS
    Eur Urol; 2018 Nov; 74(5):597-608. PubMed ID: 30017405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.
    Suer E; Hamidi N; Gokce MI; Gulpinar O; Turkolmez K; Beduk Y; Baltaci S
    World J Urol; 2016 Jun; 34(6):847-51. PubMed ID: 26462931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Review on the Role of Repeat Transurethral Resection after Initial en Bloc Resection for Non-Muscle Invasive Bladder Cancer.
    Hu H; Zhou M; Yang B; Zhou S; Liu Z; Zhang J
    J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?
    Kitamura H; Kakehi Y
    Jpn J Clin Oncol; 2015 Apr; 45(4):315-22. PubMed ID: 25583419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Repeat Transurethral Resection Always Needed in High-Grade T1 Bladder Cancer?
    Calò B; Chirico M; Fortunato F; Sanguedolce F; Carvalho-Dias E; Autorino R; Carrieri G; Cormio L
    Front Oncol; 2019; 9():465. PubMed ID: 31214506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Tseng WH; Liu CL; Huang SK; Liao AC; Kuo JR; Hun SH; Chen CH; Su CC; Wang JC; Lee KH; Shen KH; Li CF
    Int Urol Nephrol; 2019 Aug; 51(8):1335-1342. PubMed ID: 31129781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors].
    Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.
    Sauer R; Birkenhake S; Kühn R; Wittekind C; Schrott KM; Martus P
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):121-7. PubMed ID: 9422567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat transurethral resection is still an essential tool in treating non-muscle invasive bladder cancer: the Western Australian experience.
    Chang DTS; Picardo A
    Bladder (San Franc); 2020; 7(2):e42. PubMed ID: 32775484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non-muscle-invasive Bladder Cancer: Con.
    Gontero P; Livoti S; Soria F
    Eur Urol Focus; 2023 Jul; 9(4):559-560. PubMed ID: 37005168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial.
    Liem EIML; McCormack M; Chan ESY; Matsui Y; Geavlete P; Choi YD; de Reijke TM; Farahat Y; Inman BA; de la Rosette JJMCH; Naito S
    Urol Oncol; 2018 Jul; 36(7):338.e1-338.e11. PubMed ID: 29661592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrow Band Imaging reduces persistence of cancer in patients with pT1 high grade bladder cancer.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Mavilla L; Tariciotti P; Rizzo G; Fabi F; Falavolti C; Aloisi P; Vincenti G; Tema G; Lombardo R
    Eur J Surg Oncol; 2019 Mar; 45(3):466-470. PubMed ID: 30041940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.